SIRPG
geneOn this page
Also known as bA77C3.1SIRP-B2SIRPgammaCD172g
Summary
SIRPG (signal regulatory protein gamma, HGNC:15757) is a protein-coding gene on chromosome 20p13, encoding Signal-regulatory protein gamma (Q9P1W8). Probable immunoglobulin-like cell surface receptor.
The protein encoded by this gene is a member of the signal-regulatory protein (SIRP) family, and also belongs to the immunoglobulin superfamily. SIRP family members are receptor-type transmembrane glycoproteins known to be involved in the negative regulation of receptor tyrosine kinase-coupled signaling processes. Alternatively spliced transcript variants encoding different isoforms have been described.
Source: NCBI Gene 55423 — RefSeq curated summary.
At a glance
- Gene–disease (curated): male infertility with azoospermia or oligozoospermia due to single gene mutation (Limited, GenCC)
- GWAS associations: 7
- Clinical variants (ClinVar): 105 total — 1 likely-pathogenic
- MANE Select transcript:
NM_018556
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:15757 |
| Approved symbol | SIRPG |
| Name | signal regulatory protein gamma |
| Location | 20p13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | bA77C3.1, SIRP-B2, SIRPgamma, CD172g |
| Ensembl gene | ENSG00000089012 |
| Ensembl biotype | protein_coding |
| OMIM | 605466 |
| Entrez | 55423 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 6 protein_coding, 2 protein_coding_CDS_not_defined
ENST00000216927, ENST00000303415, ENST00000344103, ENST00000381580, ENST00000381583, ENST00000478145, ENST00000497407, ENST00000885694
RefSeq mRNA: 3 — MANE Select: NM_018556
NM_001039508, NM_018556, NM_080816
CCDS: CCDS13020, CCDS13021, CCDS33434
Canonical transcript exons
ENST00000303415 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001165592 | 1629152 | 1629636 |
| ENSE00001328167 | 1657642 | 1657779 |
| ENSE00001681257 | 1635267 | 1635599 |
| ENSE00001765869 | 1636188 | 1636505 |
| ENSE00003459720 | 1649052 | 1649408 |
| ENSE00003610532 | 1630222 | 1630306 |
Expression profiles
Bgee: expression breadth ubiquitous, 149 present calls, max score 98.68.
FANTOM5 (CAGE): breadth broad, TPM avg 2.6774 / max 214.4057, expressed in 362 samples.
FANTOM5 promoters (8 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 186026 | 2.6774 | 362 |
| 186044 | 1.9927 | 118 |
| 186043 | 0.4620 | 73 |
| 186029 | 0.4102 | 179 |
| 186027 | 0.1564 | 70 |
| 186028 | 0.1548 | 84 |
| 186024 | 0.0730 | 37 |
| 186042 | 0.0068 | 3 |
Top tissues by expression
272 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 98.68 | gold quality |
| buccal mucosa cell | CL:0002336 | 88.99 | silver quality |
| lymph node | UBERON:0000029 | 87.98 | gold quality |
| granulocyte | CL:0000094 | 82.66 | gold quality |
| blood | UBERON:0000178 | 82.11 | gold quality |
| vermiform appendix | UBERON:0001154 | 81.09 | gold quality |
| spleen | UBERON:0002106 | 80.52 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 79.70 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 77.10 | gold quality |
| caecum | UBERON:0001153 | 75.55 | gold quality |
| left testis | UBERON:0004533 | 73.15 | gold quality |
| right testis | UBERON:0004534 | 72.89 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 72.14 | gold quality |
| thymus | UBERON:0002370 | 70.91 | silver quality |
| rectum | UBERON:0001052 | 70.85 | gold quality |
| bone marrow cell | CL:0002092 | 70.27 | gold quality |
| bone marrow | UBERON:0002371 | 70.03 | gold quality |
| testis | UBERON:0000473 | 70.00 | gold quality |
| gall bladder | UBERON:0002110 | 69.29 | gold quality |
| small intestine | UBERON:0002108 | 68.51 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 67.68 | gold quality |
| superficial temporal artery | UBERON:0001614 | 67.57 | silver quality |
| tonsil | UBERON:0002372 | 67.43 | gold quality |
| parotid gland | UBERON:0001831 | 66.92 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 65.77 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 62.89 | gold quality |
| transverse colon | UBERON:0001157 | 61.56 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 60.39 | gold quality |
| biceps brachii | UBERON:0001507 | 59.99 | gold quality |
| right coronary artery | UBERON:0001625 | 59.56 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.65 |
| E-HCAD-30 | no | 68.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
41 targeting SIRPG, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4425 | 100.00 | 67.59 | 1049 |
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-4731-5P | 99.89 | 67.23 | 2537 |
| HSA-MIR-6780A-5P | 99.88 | 66.69 | 2776 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
| HSA-MIR-1273H-5P | 99.77 | 66.32 | 2471 |
| HSA-MIR-3934-3P | 99.76 | 65.51 | 1351 |
| HSA-MIR-149-3P | 99.72 | 68.22 | 3963 |
| HSA-MIR-30B-3P | 99.70 | 65.76 | 2325 |
| HSA-MIR-3689A-3P | 99.70 | 65.73 | 2306 |
| HSA-MIR-3689B-3P | 99.70 | 65.71 | 2311 |
| HSA-MIR-3689C | 99.70 | 65.71 | 2311 |
| HSA-MIR-6779-5P | 99.70 | 65.76 | 2363 |
| HSA-MIR-6883-5P | 99.69 | 68.05 | 3785 |
| HSA-MIR-7106-5P | 99.53 | 67.47 | 3574 |
| HSA-MIR-1207-5P | 99.49 | 69.11 | 2983 |
| HSA-MIR-940 | 99.37 | 66.14 | 2064 |
| HSA-MIR-6808-5P | 99.31 | 66.23 | 2150 |
| HSA-MIR-6893-5P | 99.31 | 66.25 | 2119 |
| HSA-MIR-504-3P | 99.30 | 67.18 | 1745 |
| HSA-MIR-4505 | 99.27 | 67.81 | 2678 |
| HSA-MIR-5787 | 99.22 | 67.86 | 2628 |
| HSA-MIR-3925-5P | 99.21 | 67.90 | 1466 |
| HSA-MIR-6799-5P | 99.14 | 65.72 | 2093 |
| HSA-MIR-4763-3P | 99.10 | 67.83 | 2649 |
| HSA-MIR-6877-3P | 98.98 | 65.83 | 560 |
Literature-anchored findings (GeneRIF, showing 8)
- a novel member of the signal regulatory protein (SIRP) family- with unique characteristics from both alpha and beta genes- termed SIRPgamma (PMID:15294972)
- CD47 is enriched at endothelial junctions, and its interaction with SIRPgamma is required for human T-cell transendothelial migration (PMID:18524990)
- tumor necrosis factor receptor superfamily, member 14 (TNFRSF14) and signal regulatory protein, gamma (SIRPG) appear to contribute to gender difference in incidence of systemic lupus erythematosus. (PMID:19473566)
- SIRPgamma in complex with FabOX117 forms a dimer in the crystal. Binding to the Fab fixes the position of domain 1 relative to domains 2/3 exposing a surface which favours formation of a homotypic dimer. (PMID:23826770)
- The independent non-obstructive azoospermia risk alleles are driven by variants in the protein-coding sequence of the two genes, SIRPA and SIRPG. (PMID:24162948)
- The SNP rs2281808 TT variant reduced SIRPgamma expression on T-cells. SIRPgamma(low) CD8 T-cells in CT and TT individuals were in a heightened effector state with lower activation threshold and had greater gene expression of molecules associated with migratory and cytotoxic potential. SIRPgamma(low) CD8 T-cells were deficient in transcription factors associated with long-term functional memory formation. (PMID:30337675)
- Altered expression of SIRPgamma on the T-cells of relapsing remitting multiple sclerosis and type 1 diabetes patients could potentiate effector responses from T-cells. (PMID:32853219)
- Genetic Control of Splicing at SIRPG Modulates Risk of Type 1 Diabetes. (PMID:34799406)
Cross-species orthologs
9 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Sirpa | ENSMUSG00000037902 |
| mus_musculus | Sirpb1c | ENSMUSG00000074677 |
| mus_musculus | Gm5150 | ENSMUSG00000078780 |
| mus_musculus | Sirpd | ENSMUSG00000078783 |
| mus_musculus | Sirpb1b | ENSMUSG00000095028 |
| mus_musculus | Sirpb1a | ENSMUSG00000095788 |
| rattus_norvegicus | Sirpa | ENSRNOG00000004763 |
| rattus_norvegicus | LOC100909964 | ENSRNOG00000043478 |
| rattus_norvegicus | AABR07008876.1 | ENSRNOG00000053292 |
Paralogs (4): SIRPB1 (ENSG00000101307), SIRPD (ENSG00000125900), SIRPB2 (ENSG00000196209), SIRPA (ENSG00000198053)
Protein
Protein identifiers
Signal-regulatory protein gamma — Q9P1W8 (reviewed: Q9P1W8)
Alternative names: CD172 antigen-like family member B, Signal-regulatory protein beta-2
All UniProt accessions (1): Q9P1W8
UniProt curated annotations — full annotation on UniProt →
Function. Probable immunoglobulin-like cell surface receptor. On binding with CD47, mediates cell-cell adhesion. Engagement on T-cells by CD47 on antigen-presenting cells results in enhanced antigen-specific T-cell proliferation and costimulates T-cell activation.
Subunit / interactions. Interacts with CD47.
Subcellular location. Membrane.
Tissue specificity. Detected in liver, and at very low levels in brain, heart, lung, pancreas, kidney, placenta and skeletal muscle. Expressed on CD4+ T-cells, CD8+ T-cells, CD56-bright natural killer (NK) cells, CD20+ cells, and all activated NK cells. Mainly present in the paracortical T-cell area of lymph nodes, with only sparse positive cells in the mantle and in the germinal center of B-cell follicles. In the thymus, primarily expressed in the medulla on mature T-lymphocytes that have undergone thymic selection.
Isoforms (4)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9P1W8-1 | 1 | yes |
| Q9P1W8-2 | 2 | |
| Q9P1W8-3 | 3 | |
| Q9P1W8-4 | 4 |
RefSeq proteins (3): NP_001034597, NP_061026, NP_543006 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR003597 | Ig_C1-set | Domain |
| IPR003599 | Ig_sub | Domain |
| IPR007110 | Ig-like_dom | Domain |
| IPR013106 | Ig_V-set | Domain |
| IPR013783 | Ig-like_fold | Homologous_superfamily |
| IPR036179 | Ig-like_dom_sf | Homologous_superfamily |
| IPR051755 | Ig-like_CS_Receptor | Family |
Pfam: PF07654, PF07686
UniProt features (48 total): strand 25, glycosylation site 4, disulfide bond 3, splice variant 3, domain 3, sequence variant 2, topological domain 2, helix 2, signal peptide 1, chain 1, transmembrane region 1, turn 1
Structure
Experimental structures (PDB)
2 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 2JJW | X-RAY DIFFRACTION | 1.7 |
| 4I2X | X-RAY DIFFRACTION | 2.48 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9P1W8-F1 | 85.93 | 0.70 |
Antibody-complex structures (SAbDab): 1 — 4I2X
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (3): 53–119, 168–226, 271–329
Glycosylation sites (4): 309, 317, 243, 268
Function
Pathways and Gene Ontology
Reactome pathways
4 pathways
| ID | Pathway |
|---|---|
| R-HSA-202733 | Cell surface interactions at the vascular wall |
| R-HSA-391160 | Signal regulatory protein family interactions |
| R-HSA-109582 | Hemostasis |
| R-HSA-1500931 | Cell-Cell communication |
MSigDB gene sets: 159 (showing top):
GOBP_REGULATION_OF_CELL_ACTIVATION, GOBP_POSITIVE_REGULATION_OF_ENDOCYTOSIS, GOBP_VESICLE_MEDIATED_TRANSPORT, GOBP_CELL_CELL_SIGNALING, GOBP_REGULATION_OF_VESICLE_MEDIATED_TRANSPORT, GOBP_POSITIVE_REGULATION_OF_CELL_ADHESION, GOBP_CELL_CELL_ADHESION, GOBP_POSITIVE_REGULATION_OF_CELL_ACTIVATION, GOBP_POSITIVE_REGULATION_OF_PHAGOCYTOSIS, GOBP_REGULATION_OF_ENDOCYTOSIS, GOBP_LEUKOCYTE_CELL_CELL_ADHESION, GOBP_POSITIVE_REGULATION_OF_CELL_CELL_ADHESION, GOBP_REGULATION_OF_PHAGOCYTOSIS, GOBP_POSITIVE_REGULATION_OF_TRANSPORT, GOBP_REGULATION_OF_TRANSPORT
GO Biological Process (8): cell adhesion (GO:0007155), cell-cell signaling (GO:0007267), positive regulation of cell population proliferation (GO:0008284), negative regulation of cell population proliferation (GO:0008285), positive regulation of cell-cell adhesion (GO:0022409), intracellular signal transduction (GO:0035556), positive regulation of phagocytosis (GO:0050766), positive regulation of T cell activation (GO:0050870)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Hemostasis | 1 |
| Cell-Cell communication | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cell population proliferation | 2 |
| regulation of cell population proliferation | 2 |
| cellular process | 1 |
| cell communication | 1 |
| signaling | 1 |
| positive regulation of cellular process | 1 |
| negative regulation of cellular process | 1 |
| regulation of cell-cell adhesion | 1 |
| positive regulation of cell adhesion | 1 |
| cell-cell adhesion | 1 |
| intracellular anatomical structure | 1 |
| signal transduction | 1 |
| phagocytosis | 1 |
| positive regulation of endocytosis | 1 |
| regulation of phagocytosis | 1 |
| T cell activation | 1 |
| regulation of T cell activation | 1 |
| positive regulation of lymphocyte activation | 1 |
| positive regulation of leukocyte cell-cell adhesion | 1 |
| binding | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
1428 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SIRPG | CD47 | Q08722 | 998 |
| SIRPG | TYROBP | O43914 | 737 |
| SIRPG | CD3E | P07766 | 483 |
| SIRPG | LGALS9 | O00182 | 447 |
| SIRPG | CD44 | P16070 | 442 |
| SIRPG | SH2D1A | O60880 | 437 |
| SIRPG | SIRPA | P78324 | 434 |
| SIRPG | UBASH3A | P57075 | 431 |
| SIRPG | LCK | P06239 | 412 |
| SIRPG | TMIGD2 | Q96BF3 | 354 |
| SIRPG | UBE2U | Q5VVX9 | 352 |
| SIRPG | RIPK1 | Q13546 | 349 |
| SIRPG | CD6 | P30203 | 348 |
| SIRPG | ASAP1 | Q9ULH1 | 348 |
| SIRPG | SLA2 | Q9H6Q3 | 344 |
IntAct
12 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SIRPG | CD47 | psi-mi:“MI:0915”(physical association) | 0.710 |
| SIRPG | CD47 | psi-mi:“MI:0407”(direct interaction) | 0.710 |
| SIRPG | FOS | psi-mi:“MI:0915”(physical association) | 0.560 |
| SIRPG | GATM | psi-mi:“MI:0915”(physical association) | 0.560 |
| SIRPG | SIRPA | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (8): SIRPA (Affinity Capture-MS), SPCS2 (Affinity Capture-MS), LTF (Affinity Capture-MS), SIRPA (Affinity Capture-MS), LTF (Affinity Capture-MS), SIRPA (Affinity Capture-MS), SIRPG (Protein-peptide), SIRPG (Affinity Capture-MS)
ESM2 similar proteins: A0A140LHF2, A0JPB1, A8E0Y8, D3YX43, O00241, P01833, P01854, P01874, P01879, P01880, P0C788, P0DOX3, P0DOX4, P0DOX6, P0DUB1, P15083, P20273, P20768, P27931, P35590, P35916, P35917, P35969, P43121, P43303, P53767, P81265, Q06805, Q06806, Q15109, Q5FWR8, Q5TFQ8, Q5U5A3, Q62230, Q62786, Q6AYD4, Q8K135, Q8R2Y2, Q91ZT1, Q925F2
Diamond homologs: O00241, O46631, P01691, P01844, P01845, P01847, P01915, P04230, P04231, P18211, P18468, P18469, P18470, P20040, P78324, P97710, P97797, Q5JXA9, Q5TFQ8, Q9H106, Q9P1W8, Q9PWR4, P55899, Q29980, P01835, P35737, P01634, P01645, P01646, P01861, P20760, P01693, P01635, P01683, P14432
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
105 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 1 |
| Uncertain significance | 74 |
| Likely benign | 15 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 564643 | GRCh37/hg19 20p13(chr20:61568-2010334)x1 | Likely pathogenic |
SpliceAI
1719 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 20:1477404:C:CC | acceptor_gain | 1.0000 |
| 20:1630220:A:AC | donor_gain | 1.0000 |
| 20:1630221:C:CC | donor_gain | 1.0000 |
| 20:1630221:CAG:C | donor_gain | 1.0000 |
| 20:1630221:CAGT:C | donor_gain | 1.0000 |
| 20:1477399:TTTTG:T | acceptor_gain | 0.9900 |
| 20:1477400:TTTG:T | acceptor_gain | 0.9900 |
| 20:1477401:TTG:T | acceptor_gain | 0.9900 |
| 20:1477402:TG:T | acceptor_gain | 0.9900 |
| 20:1479804:T:TC | acceptor_gain | 0.9900 |
| 20:1491270:CTTA:C | donor_loss | 0.9900 |
| 20:1491271:TTACC:T | donor_loss | 0.9900 |
| 20:1491272:TACCT:T | donor_loss | 0.9900 |
| 20:1491273:A:AT | donor_loss | 0.9900 |
| 20:1491274:C:CT | donor_loss | 0.9900 |
| 20:1630213:TGTAC:T | donor_loss | 0.9900 |
| 20:1630214:GTAC:G | donor_loss | 0.9900 |
| 20:1630215:TACT:T | donor_loss | 0.9900 |
| 20:1630216:ACTTA:A | donor_loss | 0.9900 |
| 20:1630217:CT:C | donor_loss | 0.9900 |
| 20:1630218:TTACA:T | donor_loss | 0.9900 |
| 20:1630219:TAC:T | donor_loss | 0.9900 |
| 20:1630220:ACAGT:A | donor_gain | 0.9900 |
| 20:1630221:C:A | donor_loss | 0.9900 |
| 20:1630221:CA:C | donor_gain | 0.9900 |
| 20:1630221:CAGTC:C | donor_gain | 0.9900 |
| 20:1630307:C:CC | acceptor_gain | 0.9900 |
| 20:1631228:G:C | donor_gain | 0.9900 |
| 20:1649043:TGTAC:T | donor_loss | 0.9900 |
| 20:1649044:GTACT:G | donor_loss | 0.9900 |
AlphaMissense
2499 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 20:1635520:G:C | F276L | 0.984 |
| 20:1635520:G:T | F276L | 0.984 |
| 20:1635522:A:G | F276L | 0.984 |
| 20:1636417:G:C | F173L | 0.978 |
| 20:1636417:G:T | F173L | 0.978 |
| 20:1636419:A:G | F173L | 0.978 |
| 20:1649284:C:A | W66C | 0.959 |
| 20:1649284:C:G | W66C | 0.959 |
| 20:1649286:A:G | W66R | 0.949 |
| 20:1649286:A:T | W66R | 0.949 |
| 20:1649324:C:G | C53S | 0.949 |
| 20:1649325:A:T | C53S | 0.949 |
| 20:1636392:A:G | W182R | 0.945 |
| 20:1636392:A:T | W182R | 0.945 |
| 20:1649176:A:C | F102L | 0.940 |
| 20:1649176:A:T | F102L | 0.940 |
| 20:1649178:A:G | F102L | 0.940 |
| 20:1649126:C:G | C119S | 0.937 |
| 20:1649127:A:T | C119S | 0.937 |
| 20:1649119:C:A | K121N | 0.934 |
| 20:1649119:C:G | K121N | 0.934 |
| 20:1649116:A:C | F122L | 0.933 |
| 20:1649116:A:T | F122L | 0.933 |
| 20:1649118:A:G | F122L | 0.933 |
| 20:1636309:G:C | S209R | 0.924 |
| 20:1636309:G:T | S209R | 0.924 |
| 20:1636311:T:G | S209R | 0.924 |
| 20:1649281:G:C | F67L | 0.924 |
| 20:1649281:G:T | F67L | 0.924 |
| 20:1649283:A:G | F67L | 0.924 |
dbSNP variants (sampled 300 via entrez): RS1000130160 (20:1687227 G>A,T), RS1000145278 (20:1629266 C>G), RS1000397217 (20:1681068 A>G), RS1000450687 (20:1660430 C>G), RS1000457737 (20:1676986 G>A), RS1000537367 (20:1661121 C>T), RS1000545787 (20:1639097 T>C), RS1000549613 (20:1630526 G>A,T), RS1000571927 (20:1677293 C>T), RS1000588431 (20:1661342 A>G), RS1000690414 (20:1655238 G>A), RS1000739203 (20:1671598 TG>T), RS1000755057 (20:1634577 A>G), RS1000829942 (20:1650232 C>A), RS1000841577 (20:1665563 C>A)
Disease associations
OMIM: gene MIM:605466 | disease phenotypes:
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| male infertility with azoospermia or oligozoospermia due to single gene mutation | Limited | Autosomal recessive |
Mondo (1): (MONDO:0018393)
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
7 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001979_3 | Circulating myeloperoxidase levels (serum) | 4.000000e-08 |
| GCST005576_19 | Intracranial aneurysm | 2.000000e-06 |
| GCST006585_981 | Blood protein levels | 2.000000e-19 |
| GCST008499_2 | Meningococcal C functional antibody titers post childhood immunization | 7.000000e-07 |
| GCST008499_3 | Meningococcal C functional antibody titers post childhood immunization | 8.000000e-06 |
| GCST008499_4 | Meningococcal C functional antibody titers post childhood immunization | 6.000000e-07 |
| GCST010396_302 | Gut microbiota (bacterial taxa, hurdle binary method) | 5.000000e-06 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005243 | myeloperoxidase measurement |
| EFO:0004645 | response to vaccine |
| EFO:0007874 | gut microbiome measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
13 total (human), top 13 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| butyraldehyde | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Diuron | decreases expression | 1 |
| Endosulfan | decreases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Methyl Methanesulfonate | decreases expression | 1 |
| Nickel | increases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Cadmium Chloride | increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 spontaneously immortalized cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_KA61 | CHO-K1/SIRP gamma | Spontaneously immortalized cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): brain aneurysm